PhenixFIN Corp (PFX) stock
PFXNasdaqFiscal year ends September 30Also trades as PFXNZ
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 5/3032% below fair value
$40.17+0.77 (+1.95%)
Close on Nov 20, 2026Market cap $77.58MP/E 16.6Yield –
PhenixFIN EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
PhenixFIN's EPS for the twelve months ending Jun 30, 2026 was $2.42, down 20.9% year over year. For fiscal 2025 it was $2.06, down 77.4% from the year before. The highest annual figure on record is $12.87 in fiscal 2023.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $2.06 | -77.4% |
| FY2024 | Sep 30, 2024 | $9.13 | -29.1% |
| FY2023 | Sep 30, 2023 | $12.87 | – |
| FY2022 | Sep 30, 2022 | -$2.63 | -647.9% |
| FY2021 | Sep 30, 2021 | $0.48 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $2.19 | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $0.57 | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$2.38 | -295.1% |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $2.04 | -32.5% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$0.74 | -157.4% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -$0.44 | -116.8% |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | $1.22 | -44.3% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $3.02 | -29.1% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $1.29 | -59.7% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | $2.62 | +39.4% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $2.19 | – |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $4.26 | +243.5% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $3.20 | – |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $1.88 | – |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -$4.19 | – |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $1.24 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?